Stay Connected With Us
We want to provide information and news that's relevant to you.
Stay ConnectedOur Research
R&D Pipeline
Phase II/III Hemophilia Clinical Trial Purpose
Biogen Idec Hemophilia is researching innovative, fully recombinant clotting factor replacement products that are being explored for their potential to provide prolonged protection from bleeding.